Mekinist 2 MG tablet UU 30S

Ended Awarded

Contract number
SPE2DX23FRTDV
Awardee
Awarding agency
Obligated
$8,624

Award facts

Contract value 100% obligated
$8,623.89 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
325411 Medicinal and Botanical Manufacturing
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Conshohocken, PA 19428, USA

Award details come from SAM.gov/FPDS.

About this award

Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, has been awarded a $8,623.89 firm fixed price delivery order by the Defense Logistics Agency Troop Support Medical to supply 4561421807 MEKINIST 2 MG tablets. The delivery order, which runs from July 6, 2023 through July 27, 2023, calls for Amerisourcebergen to provide 30 tablets of MEKINIST, a cancer treatment drug, for use by the Defense Department. Performance will take place in Conshohocken, Pennsylvania. Funding is provided by the Defense Logistics Agency Troop Support Medical in support of its mission to procure pharmaceuticals and medical supplies for the U.S. military. No set aside designation or subcontractors are indicated.

Quick answers

Who was awarded contract SPE2DX23FRTDV?

SPE2DX23FRTDV was awarded to Amerisourcebergen Drug Corp by Medical Supply Chain (Troop Support) on July 6, 2023.

How much is contract SPE2DX23FRTDV worth?

The government has obligated $8,624 on SPE2DX23FRTDV.

Is contract SPE2DX23FRTDV an order under another contract?

Yes. SPE2DX23FRTDV is a delivery order under SPE2DX15D3020, an indefinite delivery contract.

Was contract SPE2DX23FRTDV competed?

The extent of competition for SPE2DX23FRTDV was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award